{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:41:20Z","timestamp":1790523680248,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81460464"],"award-info":[{"award-number":["81460464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Applied Foundation Key Project of Yunnan Province","award":["2013FA059"],"award-info":[{"award-number":["2013FA059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4989-y","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T12:24:23Z","timestamp":1542025463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Fang-Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Lun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"issue":"4","key":"4989_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"20","key":"4989_CR2","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med. 2007;357(20):2040\u20138.","journal-title":"N Engl J Med"},{"issue":"22","key":"4989_CR3","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1200\/JCO.2007.11.5956","volume":"25","author":"A Sartore-Bianchi","year":"2007","unstructured":"Sartore-Bianchi A, Moroni M, Veronese S, Carnaghi C, Bajetta E, Luppi G, Sobrero A, Barone C, Cascinu S, Colucci G, et al. Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab. J Clin Oncol. 2007;25(22):3238\u201345.","journal-title":"J Clin Oncol"},{"issue":"26","key":"4989_CR4","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.3748\/wjg.v21.i26.7944","volume":"21","author":"G Del Vecchio Blanco","year":"2015","unstructured":"Del Vecchio Blanco G, Paoluzi OA, Sileri P, Rossi P, Sica G, Pallone F. Familial colorectal cancer screening: when and what to do? World J Gastroenterol. 2015;21(26):7944\u201353.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4989_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/bjc.2013.753","volume":"110","author":"DJ Jonker","year":"2014","unstructured":"Jonker DJ, Karapetis CS, Harbison C, O'Callaghan CJ, Tu D, Simes RJ, Malone DP, Langer C, Tebbutt N, Price TJ, et al. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. Br J Cancer. 2014;110(3):648\u201355.","journal-title":"Br J Cancer"},{"issue":"3","key":"4989_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/mt.2012.257","volume":"21","author":"P Sampath","year":"2013","unstructured":"Sampath P, Li J, Hou W, Chen H, Bartlett DL, Thorne SH. Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects. Mol Ther. 2013;21(3):620\u20138.","journal-title":"Mol Ther"},{"issue":"2","key":"4989_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1309\/AJCP7FO2VAXIVSTP","volume":"135","author":"X Liu","year":"2011","unstructured":"Liu X, Jakubowski M, Hunt JL. KRAS gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis. Am J Clin Pathol. 2011;135(2):245\u201352.","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 4","key":"4989_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/annonc\/mdf665","volume":"13","author":"U McDermott","year":"2002","unstructured":"McDermott U, Longley DB, Johnston PG. Molecular and biochemical markers in colorectal cancer. Ann Oncol. 2002;13(Suppl 4):235\u201345.","journal-title":"Ann Oncol"},{"issue":"5986","key":"4989_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/311562a0","volume":"311","author":"A Thor","year":"1984","unstructured":"Thor A, Horan Hand P, Wunderlich D, Caruso A, Muraro R, Schlom J. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases. Nature. 1984;311(5986):562\u20135.","journal-title":"Nature"},{"key":"4989_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12885-016-2168-6","volume":"16","author":"JL Yang","year":"2016","unstructured":"Yang JL, Liu DX, Zhen SJ, Zhou YG, Zhang DJ, Yang LY, Chen HB, Feng Q. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues. BMC Cancer. 2016;16:131.","journal-title":"BMC Cancer"},{"issue":"5","key":"4989_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/j.1745-7254.2008.00779.x","volume":"29","author":"H Sun","year":"2008","unstructured":"Sun H, Liu B, Yang YP, Xu CX, Yan YF, Wang W, Liu XX. Adenovirus-mediated expression of SSAT inhibits colorectal cancer cell growth in vitro. Acta Pharmacol Sin. 2008;29(5):606\u201313.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"4989_CR12","first-page":"1435","volume":"61","author":"Z Lin","year":"2015","unstructured":"Lin Z, Ren N, Jiang Y, Xu W, Shi Y, Liu G. Adenovirus-mediated E2F-1 gene transfer augments gemcitabine-induced apoptosis in human Colon Cancer cells. Clin Lab. 2015;61(10):1435\u201344.","journal-title":"Clin Lab"},{"issue":"1","key":"4989_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/abio.1995.1020","volume":"224","author":"CE Mitchell","year":"1995","unstructured":"Mitchell CE, Belinsky SA, Lechner JF. Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis. Anal Biochem. 1995;224(1):148\u201353.","journal-title":"Anal Biochem"},{"issue":"6","key":"4989_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1248\/bpb.32.968","volume":"32","author":"H Shi","year":"2009","unstructured":"Shi H, Jin H, Chu D, Wang W, Zhang J, Chen C, Xu C, Fan D, Yao L. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull. 2009;32(6):968\u201375.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"4989_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2012.09.003","volume":"328","author":"X Dong","year":"2013","unstructured":"Dong X, Qu W, Ma S, Zhu Z, Zheng C, He A, Karlsson A, Xu K, Zheng X. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo. Cancer Lett. 2013;328(1):95\u2013103.","journal-title":"Cancer Lett"},{"issue":"9","key":"4989_CR16","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1158\/1078-0432.CCR-16-1524","volume":"23","author":"L Gammaitoni","year":"2017","unstructured":"Gammaitoni L, Giraudo L, Macagno M, Leuci V, Mesiano G, Rotolo R, Sassi F, Sanlorenzo M, Zaccagna A, Pisacane A, et al. Cytokine-induced killer cells kill chemo-surviving melanoma Cancer stem cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(9):2277\u201388.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"4989_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2017.07.036","volume":"656","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhou L, Zheng X, Chen G, Pan R, Li J, Liu W. Autophagy protects against PI3K\/Akt\/mTOR-mediated apoptosis of spinal cord neurons after mechanical injury. Neurosci Lett. 2017;656:158\u201364.","journal-title":"Neurosci Lett"},{"issue":"1","key":"4989_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ymthe.2004.05.006","volume":"10","author":"H Uchida","year":"2004","unstructured":"Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y, Kobune M, Miyagishi M, Taira K, Tahara H, et al. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Molecular therapy : the journal of the American Society of Gene Therapy. 2004;10(1):162\u201371.","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"issue":"50","key":"4989_CR19","doi-asserted-by":"crossref","first-page":"83017","DOI":"10.18632\/oncotarget.12940","volume":"7","author":"T Lu","year":"2016","unstructured":"Lu T, Zou Y, Xu G, Potter JA, Taylor GL, Duan Q, Yang Q, Xiong H, Qiu H, Ye D, et al. PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK. Oncotarget. 2016;7(50):83017\u201330.","journal-title":"Oncotarget"},{"issue":"11","key":"4989_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s11655-017-2775-3","volume":"23","author":"LH Wei","year":"2017","unstructured":"Wei LH, Lin JM, Chu JF, Chen HW, Li QY, Peng J. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt\/beta-catenin signaling pathway. Chinese journal of integrative medicine. 2017;23(11):858\u201363.","journal-title":"Chinese journal of integrative medicine"},{"issue":"6","key":"4989_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0002-9440(10)64833-X","volume":"157","author":"R Palmqvist","year":"2000","unstructured":"Palmqvist R, Ruteg\u00e2rd JN, Bozoky B, Landberg G, Stenling R. Human colorectal cancers with an intact p16\/cyclin D1\/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol. 2000;157(6):1947\u201353.","journal-title":"Am J Pathol"},{"issue":"12","key":"4989_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1089\/hum.2009.163","volume":"20","author":"SM Thomas","year":"2009","unstructured":"Thomas SM, Grandis JR. The current state of head and neck cancer gene therapy. Hum Gene Ther. 2009;20(12):1565\u201375.","journal-title":"Hum Gene Ther"},{"issue":"11","key":"4989_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.cr.7310108","volume":"16","author":"XY Liu","year":"2006","unstructured":"Liu XY. Targeting gene-virotherapy of cancer and its prosperity. Cell Res. 2006;16(11):879\u201386.","journal-title":"Cell Res"},{"issue":"4","key":"4989_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00109-007-0291-1","volume":"86","author":"DM Nettelbeck","year":"2008","unstructured":"Nettelbeck DM. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer. J Mol Med (Berl). 2008;86(4):363\u201377.","journal-title":"J Mol Med (Berl)"},{"issue":"7362","key":"4989_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10358","volume":"477","author":"CJ Breitbach","year":"2011","unstructured":"Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, Nieva J, Hwang TH, Moon A, Patt R, et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature. 2011;477(7362):99\u2013102.","journal-title":"Nature"},{"issue":"2","key":"4989_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jconrel.2011.06.014","volume":"155","author":"OJ Kwon","year":"2011","unstructured":"Kwon OJ, Kang E, Kim S, Yun CO. Viral genome DNA\/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery. Journal of controlled release : official journal of the Controlled Release Society. 2011;155(2):317\u201325.","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"issue":"10","key":"4989_CR27","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","volume":"75","author":"MA Croyle","year":"2001","unstructured":"Croyle MA, Chirmule N, Zhang Y, Wilson JM. \u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon Readministration in the lung. J Virol. 2001;75(10):4792\u2013801.","journal-title":"J Virol"},{"issue":"9","key":"4989_CR28","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","volume":"32","author":"PH Kim","year":"2011","unstructured":"Kim PH, Sohn JH, Choi JW, Jung Y, Kim SW, Haam S, Yun CO. Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials. 2011;32(9):2314\u201326.","journal-title":"Biomaterials"},{"issue":"5768","key":"4989_CR29","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1126\/science.1121411","volume":"311","author":"SH Thorne","year":"2006","unstructured":"Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science. 2006;311(5768):1780\u20134.","journal-title":"Science"},{"issue":"2","key":"4989_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12185-014-1618-7","volume":"100","author":"H Wang","year":"2014","unstructured":"Wang H, Cao F, Li J, Li Y, Liu X, Wang L, Liu Z, Zhao H, Zhou J. Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia. Int J Hematol. 2014;100(2):165\u201370.","journal-title":"Int J Hematol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4989-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4989-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4989-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T03:10:04Z","timestamp":1605409804000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4989-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4989"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4989-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received the approval of the Ethics Board of Kunming General Hospital and was also conducted in accordance with the Helsinki Declaration of 1975. Animals involved in the study were cared for in accordance with institutional guidelines. No cell lines used in the work presented in this paper required Ethics approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1087"}}